Form 4: Celularity Inc. Director, Geoffrey Ling, Reports Stock and Option Awards

Director Geoffrey Ling of Celularity Inc. reports the vesting of restricted stock units and the grant of stock options.

Summary

• Geoffrey Ling, a director at Celularity Inc., reported the vesting of 67,416 restricted stock units (RSUs) on December 19, 2024.
• These RSUs, granted under the 2021 Equity Incentive Plan, each represent the right to receive one share of Celularity's Class A common stock.
• The vesting occurred on the one-year anniversary of the grant date, or the next annual stockholder meeting, contingent on continuous service.
• Additionally, Ling was granted a stock option to purchase 84,746 shares of Class A common stock at an exercise price of $2.225 per share.
• This option also vests on the earlier of December 19, 2024, or the next annual stockholder meeting, subject to continuous service.
• Following these transactions, Ling directly owns 67,416 shares and has options for 1,334,746 shares.

Sentiment

Score: 7

Explanation: The document reflects standard corporate practice of equity compensation for a director. It is a neutral event with no significant positive or negative implications.

Positives

• The vesting of RSUs and grant of stock options align the director's interests with the company's performance.
• The vesting and option grant are subject to continued service, incentivizing the director's ongoing commitment.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• The vesting of RSUs and granting of stock options are common practices for compensating directors and executives in publicly traded companies.
• The terms of the vesting and option grants, such as the one-year vesting period and the exercise price, are generally consistent with industry standards for equity compensation.

Stakeholder Impact

• The vesting of RSUs and grant of stock options may have a minor dilutive effect on existing shareholders.
• The transactions align the director's interests with those of shareholders, potentially encouraging value creation.

Key Dates

Keywords

stock options, restricted stock units, RSUs, equity incentive plan, beneficial ownership, director, Celularity Inc, CELU